Wikidata

(Q27851763)

English

Preoperative chemotherapy plus trastuzumab, lapatinib, or both in human epidermal growth factor receptor 2-positive operable breast cancer: results of the randomized phase II CHER-LOB study

scientific article

In more languages
default values for all languages
No label defined

No description defined

Statements

title
Preoperative chemotherapy plus trastuzumab, lapatinib, or both in human epidermal growth factor receptor 2-positive operable breast cancer: results of the randomized phase II CHER-LOB study (English)
1 reference
stated in
PubMed
PubMed publication ID
22493419
retrieved
13 November 2016
author name string
Valentina Guarneri
series ordinal
1
0 references
Antonio Frassoldati
series ordinal
2
0 references
Alberto Bottini
series ordinal
3
0 references
Katia Cagossi
series ordinal
4
0 references
Giancarlo Bisagni
series ordinal
5
0 references
Samanta Sarti
series ordinal
6
0 references
Alberto Ravaioli
series ordinal
7
0 references
Luigi Cavanna
series ordinal
8
0 references
Giovanni Giardina
series ordinal
9
0 references
Antonino Musolino
series ordinal
10
0 references
Laura Orlando
series ordinal
12
0 references
Fabrizio Artioli
series ordinal
13
0 references
Corrado Boni
series ordinal
14
0 references
Daniele Giulio Generali
series ordinal
15
0 references
Patrizia Serra
series ordinal
16
0 references
Michela Bagnalasta
series ordinal
17
0 references
Luca Marini
series ordinal
18
0 references
Federico Piacentini
series ordinal
19
0 references
Pierfranco Conte
series ordinal
21
0 references
publication date
1 June 2012
0 references
volume
30
0 references
issue
16
0 references
page(s)
1989-95
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q27851763&oldid=1577178723"